Clinical Trial Update: Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the safety of oral ifetroban in patients with aspirin-exacerbated respiratory disease; the study completed and results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspirin-exacerbated Respiratory Disease

Drugs mentioned

• Ifetroban (Ifetroban)

Snippet

Sponsor: Cumberland Pharmaceuticals | Conditions: Aspirin Exacerbated Respiratory Disease (AERD) | Phase 2 | Status: COMPLETED | Results posted: 2017-03-22